AR071279A1 - Derivados del acido fenilacetico como moduladores de la inflamacion , composiciones farmaceuticas y metodos de preparacion - Google Patents

Derivados del acido fenilacetico como moduladores de la inflamacion , composiciones farmaceuticas y metodos de preparacion

Info

Publication number
AR071279A1
AR071279A1 ARP080105608A ARP080105608A AR071279A1 AR 071279 A1 AR071279 A1 AR 071279A1 AR P080105608 A ARP080105608 A AR P080105608A AR P080105608 A ARP080105608 A AR P080105608A AR 071279 A1 AR071279 A1 AR 071279A1
Authority
AR
Argentina
Prior art keywords
compound
formula
cycloalkyl
chlorine
derivatives
Prior art date
Application number
ARP080105608A
Other languages
English (en)
Spanish (es)
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AR071279A1 publication Critical patent/AR071279A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ARP080105608A 2007-12-19 2008-12-19 Derivados del acido fenilacetico como moduladores de la inflamacion , composiciones farmaceuticas y metodos de preparacion AR071279A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US843307P 2007-12-19 2007-12-19

Publications (1)

Publication Number Publication Date
AR071279A1 true AR071279A1 (es) 2010-06-09

Family

ID=40564868

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080105608A AR071279A1 (es) 2007-12-19 2008-12-19 Derivados del acido fenilacetico como moduladores de la inflamacion , composiciones farmaceuticas y metodos de preparacion

Country Status (20)

Country Link
US (1) US8183293B2 (enrdf_load_stackoverflow)
EP (1) EP2231595B1 (enrdf_load_stackoverflow)
JP (1) JP5437267B2 (enrdf_load_stackoverflow)
KR (1) KR20100102668A (enrdf_load_stackoverflow)
CN (1) CN101903338A (enrdf_load_stackoverflow)
AR (1) AR071279A1 (enrdf_load_stackoverflow)
AU (1) AU2008343924B2 (enrdf_load_stackoverflow)
BR (1) BRPI0821197A2 (enrdf_load_stackoverflow)
CA (1) CA2707789A1 (enrdf_load_stackoverflow)
CL (1) CL2008003832A1 (enrdf_load_stackoverflow)
CO (1) CO6321234A2 (enrdf_load_stackoverflow)
CR (1) CR11572A (enrdf_load_stackoverflow)
EA (1) EA201001029A1 (enrdf_load_stackoverflow)
ES (1) ES2471919T3 (enrdf_load_stackoverflow)
IL (1) IL206069A0 (enrdf_load_stackoverflow)
MA (1) MA32013B1 (enrdf_load_stackoverflow)
PE (1) PE20091526A1 (enrdf_load_stackoverflow)
TN (1) TN2010000223A1 (enrdf_load_stackoverflow)
TW (1) TW200940051A (enrdf_load_stackoverflow)
WO (1) WO2009085177A1 (enrdf_load_stackoverflow)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2457900A1 (en) 2010-11-25 2012-05-30 Almirall, S.A. New pyrazole derivatives having CRTh2 antagonistic behaviour
EP2790696A1 (en) 2011-12-16 2014-10-22 Atopix Therapeutics Limited Combination of crth2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis
US9974759B2 (en) * 2013-05-31 2018-05-22 Indiana University Research And Technology Corporation Beta 2 adrenoceptor antagonists for treating orthostatic hypotension
EP4420734A3 (en) 2015-02-13 2024-11-06 Institut National de la Santé et de la Recherche Médicale Ptgdr-1 and/or ptgdr-2 antagonists for preventing and/or treating systemic lupus erythematosus
AR107928A1 (es) 2016-03-22 2018-06-28 Merck Sharp & Dohme Moduladores alostéricos de receptores de acetilcolina nicotínicos
EP3424927B1 (en) * 2017-07-04 2019-04-17 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Efficient process for the preparation of sitagliptin through a very effective preparation of the intermediate 2,4,5-trifluorophenylacetic acid

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8704158D0 (en) 1987-02-23 1987-04-01 Wellcome Found Substituted hydantoin compounds
US5849780A (en) 1992-01-30 1998-12-15 Sanofi 1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present
US5776951A (en) 1993-06-30 1998-07-07 Glaxo Wellcome Inc. Anti-atherosclerotic diaryl compounds
US5545669A (en) 1994-06-02 1996-08-13 Adams; Jerry L. Anti-inflammatory compounds
CZ289090B6 (cs) 1994-12-20 2001-10-17 F. Hoffmann-La Roche Ag Derivát arylsulfonamidu a heteroarylsulfonamidu, způsob jeho přípravy a jeho pouľití
IL128691A (en) 1996-09-12 2007-07-24 Bayer Schering Pharma Ag History of enzamidine converted by annular amino acid and history of annular hydroxy acid and their use against coagulation
US6008234A (en) 1996-09-12 1999-12-28 Berlex Laboratories, Inc. Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants
TW523506B (en) 1996-12-18 2003-03-11 Ono Pharmaceutical Co Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients
JPH11202458A (ja) 1998-01-16 1999-07-30 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料
US5929250A (en) 1997-01-23 1999-07-27 Smithkline Beecham Corporation IL-8 receptor antagonists
WO1999055663A1 (en) 1998-04-29 1999-11-04 Vertex Pharmaceuticals Incorporated Inhibitors of impdh enzyme
AR023659A1 (es) 1998-09-18 2002-09-04 Vertex Pharma Un compuesto inhibidor de p38, una composicion farmaceutica que lo comprende y el uso de dicha composicion en el tratamiento y prevencion de estados patologicos
US6248739B1 (en) 1999-01-08 2001-06-19 Pharmacia & Upjohn Company Quinolinecarboxamides as antiviral agents
KR20010103786A (ko) 1999-03-01 2001-11-23 데이비드 존 우드 갑상선 수용체 리간드로서의 옥삼산 및 유도체
DE60020226T2 (de) 1999-03-10 2006-02-02 Shionogi & Co., Ltd. Medizinische zubereitungen mit [2.2.1] und [3.1.1]bicycloskelett die antagonisten für sowohl pgd 2? als auch txa 2? rezeptoren sind
WO2001014882A1 (fr) 1999-08-23 2001-03-01 Bml, Inc. Identification des proprietes d'une substance pour les recepteurs de prostaglandine d
US6531291B1 (en) 1999-11-10 2003-03-11 The Trustees Of Columbia University In The City Of New York Antimicrobial activity of gemfibrozil and related compounds and derivatives and metabolites thereof
EP1255750A1 (en) 2000-02-01 2002-11-13 Millenium Pharmaceuticals, Inc. INDOLE AND BENZIMIDAZOLE INHIBITORS OF FACTOR Xa
US20010047027A1 (en) 2000-04-12 2001-11-29 Marc Labelle Prostaglandin D2 receptor antagonists
WO2001094309A1 (fr) 2000-06-02 2001-12-13 Shionogi & Co., Ltd. Composition medicamenteuse antagoniste pour les recepteurs de pgd2/txa2
US6878522B2 (en) 2000-07-07 2005-04-12 Baiyong Li Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
WO2002045718A1 (en) 2000-12-08 2002-06-13 Institut Pasteur De Lille Use of active compounds capable of modulating the intracellular pathway triggered by the dp receptor in langerhans cells
CA2433100A1 (en) 2000-12-27 2002-07-04 Helmut Haning Indole derivatives as ligands of thyroid receptors
US7144913B2 (en) 2001-05-23 2006-12-05 Merck Frosst Canada & Co. Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
JP4529119B2 (ja) 2001-08-09 2010-08-25 小野薬品工業株式会社 カルボン酸誘導体化合物およびその化合物を有効成分として含有する薬剤
SE0200411D0 (sv) 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
SE0200356D0 (sv) 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
ES2365985T3 (es) 2002-03-19 2011-10-14 Ono Pharmaceutical Co., Ltd. Compuestos de ácido carboxílico y fármacos que contienen los compuestos como ingrediente activo.
US7534897B2 (en) 2002-05-16 2009-05-19 Shionogi & Co., Ltd. Indole arylsulfonaimide compounds exhibiting PGD 2 receptor antagonism
JPWO2003097042A1 (ja) 2002-05-16 2005-09-15 塩野義製薬株式会社 Ｐｇｄ２受容体拮抗剤
GB2388540A (en) 2002-05-17 2003-11-19 Bayer Ag New use of Ramatroban
SE0201635D0 (sv) 2002-05-30 2002-05-30 Astrazeneca Ab Novel compounds
TW200307542A (en) 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
GB0224557D0 (en) 2002-10-22 2002-11-27 Glaxo Group Ltd Novel compounds
EP1585511B1 (en) 2002-12-20 2013-01-23 Amgen Inc. Asthma and allergic inflammation modulators
ATE386715T1 (de) 2003-11-25 2008-03-15 Lilly Co Eli Modulatoren des peroxisomproliferatoraktivierten rezeptors
WO2007039736A1 (en) * 2005-10-06 2007-04-12 Astrazeneca Ab Novel compounds
US8314147B2 (en) * 2006-12-15 2012-11-20 Glaxo Group Limited Benzamide derivatives as EP4 receptor agonists
US7960567B2 (en) 2007-05-02 2011-06-14 Amgen Inc. Compounds and methods useful for treating asthma and allergic inflammation
CN102596193A (zh) 2009-07-31 2012-07-18 潘米拉制药公司 Dp2受体拮抗的皮肤调配物
SG178109A1 (en) 2009-07-31 2012-03-29 Panmira Pharmaceuticals Llc Ophthalmic pharmaceutical compositions of dp2 receptor antagonists

Also Published As

Publication number Publication date
EA201001029A1 (ru) 2011-06-30
EP2231595A1 (en) 2010-09-29
TW200940051A (en) 2009-10-01
US8183293B2 (en) 2012-05-22
EP2231595B1 (en) 2014-04-23
CN101903338A (zh) 2010-12-01
US20090275659A1 (en) 2009-11-05
CO6321234A2 (es) 2011-09-20
IL206069A0 (en) 2010-11-30
CL2008003832A1 (es) 2010-03-26
PE20091526A1 (es) 2009-11-01
JP5437267B2 (ja) 2014-03-12
ES2471919T3 (es) 2014-06-27
MA32013B1 (fr) 2011-01-03
AU2008343924A1 (en) 2009-07-09
JP2011507847A (ja) 2011-03-10
TN2010000223A1 (en) 2011-11-11
CA2707789A1 (en) 2009-07-09
AU2008343924A2 (en) 2011-02-17
AU2008343924B2 (en) 2013-01-17
BRPI0821197A2 (pt) 2015-06-16
WO2009085177A1 (en) 2009-07-09
KR20100102668A (ko) 2010-09-24
CR11572A (es) 2010-08-13

Similar Documents

Publication Publication Date Title
AR071279A1 (es) Derivados del acido fenilacetico como moduladores de la inflamacion , composiciones farmaceuticas y metodos de preparacion
JOP20210285A1 (ar) مركبات 4h-بيرولو[3، 2-جـ]بيريدين-4-ون
MA41238A (fr) Dérivés 5-[(pipérazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione en tant qu'inhibiteurs d'adamts pour le traitement de l'ostéoarthrit
MA38403A1 (fr) Nouveaux dérivés de pyrazole modulateurs specifiques de cb2
AR059590A1 (es) Inhibidores de quinasa basados en la hidantoina
MA33783B1 (fr) Procédé de préparation de méthyl -{4,6-diamino-2-[1-(2-fluorobenzyl)- 1h-pyrazolo[3,4-b]pyridino-3-yl] pyrimidino-5-yl} méthylcarbamate et d'épuration de ce composé pour son utilisation en tant qu'agent pharmaceutique
AR081573A1 (es) N-[(het)ariletil)]pirazo(tio)carboxamidas y sus analogos heterosustituidos y su uso como fungicidas
AR052948A1 (es) DERIVADOS DE ACETILENIL-PIRAZOLO-PIRIMIDINA COMO ANTAGONISTAS DE MGLUR2, METODOS PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y SU EMPLEO EN LA FABRICACIoN DE UN MEDICAMENTO PARA EL TRATAMIENTO DE ENFERMEDADES DEL SNC
MA35434B1 (fr) Amino-quinazolines en tant qu'inhibiteurs de kinase
ATE540932T1 (de) Hydantoin-derivate als antibakterielle wirkstoffe
MA31597B1 (fr) Nouveaux herbicides
PE20180600A1 (es) Inhibidores de metalo-beta-lactamasa
MA38330B1 (fr) Dérivés d'acide phosphonique butanoïque de bisphénol substitués en qualité d'inhibiteurs de nep (endopeptidase neutre)
FR3009298B1 (fr) Procede d'exfoliation de graphite assiste par reaction de diels-alder
ITMI20022410A1 (it) Procedimento per la nitrazione di alcandioli.
AR105812A1 (es) Métodos para la preparación de inhibidores de proteína deacetilasa
EA200600605A1 (ru) Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств
EA201490998A1 (ru) Способ получения сложных эфиров (5-фтор-2-метил-3-хинолин-2-илметил-индол-1-ил)-уксусной кислоты
FR2969146B1 (fr) Procede de preparation d'ether de polyol
EA199900948A1 (ru) Способ получения 2-арил-3-арил-5-галогенпиридинов, используемых в качестве ингибиторов cox-2
AR071278A1 (es) Derivados de alfa -aminoamida utiles en el tratamiento de los trastornos psiquiatricos, y formulaciones farmaceuticas que los contienen
AR076516A1 (es) Derivados de oxa-azaespiro[3.3]heptan-6-ilo, metodo e intermediarios para su preparacion, composiciones farmaceuticas que los comprenden y su uso en el tratamiento de enfermedades mediadas por el receptor mch1.
CL2023001049A1 (es) Procedimiento para la fabricación de compuestos orgánicos
MA35906B1 (fr) Procédé de préparation d'un composé par le biais d'une nouvelle réaction d'addition de michael en utilisant de l'eau ou divers acides comme additifs
PE20120576A1 (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion farmaceuticamente aceptable

Legal Events

Date Code Title Description
FA Abandonment or withdrawal